| Date | Time | Source | Headline | Symbol | Company |
| 05/02/2024 | 8:00AM | GlobeNewswire Inc. | Aspira Women’s Health Enhances its Commercial Offering with the Formal Launch of Longitudinal Monitoring Feature of OvaWatch | NASDAQ:AWH | Aspira Womans Health Inc |
| 04/09/2024 | 8:00AM | GlobeNewswire Inc. | Aspira Women’s Health Announces Anthem Blue Cross to Provide Coverage for OvaSuite(SM) in California | NASDAQ:AWH | Aspira Womans Health Inc |
| 03/28/2024 | 7:30AM | GlobeNewswire Inc. | Aspira Women’s Health Reports Fourth Quarter and Full Year 2023 Financial Results | NASDAQ:AWH | Aspira Womans Health Inc |
| 03/25/2024 | 8:00AM | GlobeNewswire Inc. | Aspira Women’s Health Announces New Time for its Fourth Quarter and 2023 Year End Earnings Results and Call | NASDAQ:AWH | Aspira Womans Health Inc |
| 03/21/2024 | 8:00AM | GlobeNewswire Inc. | Aspira Women’s Health to Present at the MedInvest Biotech & Pharma Investor Conference | NASDAQ:AWH | Aspira Womans Health Inc |
| 03/18/2024 | 8:00AM | GlobeNewswire Inc. | Aspira Women’s Health Expands Senior Leadership Team with the Addition of Sandra Milligan, M.D., J.D. as President | NASDAQ:AWH | Aspira Womans Health Inc |
| 03/11/2024 | 8:00AM | GlobeNewswire Inc. | Aspira Women’s Health to Announce Fourth Quarter and 2023 Year End Earnings Results and Host a Conference Call on Thursday, March 28, 2024 | NASDAQ:AWH | Aspira Womans Health Inc |
| 02/22/2024 | 8:30AM | GlobeNewswire Inc. | Aspira Women’s Health to Present at The Cancer Advocacy Group of Louisiana’s 3rd Annual NeauxCancer Conference | NASDAQ:AWH | Aspira Womans Health Inc |
| 02/20/2024 | 8:54AM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:AWH | Aspira Womans Health Inc |
| 02/14/2024 | 8:17PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:AWH | Aspira Womans Health Inc |
| 02/14/2024 | 8:11PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:AWH | Aspira Womans Health Inc |
| 02/12/2024 | 8:00AM | GlobeNewswire Inc. | Aspira Women’s Health Announces Late-Breaking Poster Presentation at the Upcoming 71st Annual Scientific Meeting for the Society for Reproductive Investigation (SRI) | NASDAQ:AWH | Aspira Womans Health Inc |
| 02/07/2024 | 4:21PM | Edgar (US Regulatory) | Form D - Notice of Exempt Offering of Securities | NASDAQ:AWH | Aspira Womans Health Inc |
| 02/06/2024 | 8:00AM | GlobeNewswire Inc. | Aspira Women’s Health Announces OvaSuite(SM) Distribution Agreement in the Philippines | NASDAQ:AWH | Aspira Womans Health Inc |
| 01/30/2024 | 8:31PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:AWH | Aspira Womans Health Inc |
| 01/26/2024 | 5:25PM | Edgar (US Regulatory) | Form S-8 - Securities to be offered to employees in employee benefit plans | NASDAQ:AWH | Aspira Womans Health Inc |
| 01/26/2024 | 5:19PM | Edgar (US Regulatory) | Form 8-K/A - Current report: [Amend] | NASDAQ:AWH | Aspira Womans Health Inc |
| 01/26/2024 | 5:12PM | Edgar (US Regulatory) | Form 424B5 - Prospectus [Rule 424(b)(5)] | NASDAQ:AWH | Aspira Womans Health Inc |
| 01/25/2024 | 5:31PM | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:AWH | Aspira Womans Health Inc |
| 01/05/2024 | 4:39PM | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:AWH | Aspira Womans Health Inc |
| 12/29/2023 | 4:09PM | Edgar (US Regulatory) | Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] | NASDAQ:AWH | Aspira Womans Health Inc |
| 12/27/2023 | 7:07PM | Edgar (US Regulatory) | Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] | NASDAQ:AWH | Aspira Womans Health Inc |
| 12/27/2023 | 4:41PM | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:AWH | Aspira Womans Health Inc |
| 12/26/2023 | 5:17PM | Edgar (US Regulatory) | Form SC 13G - Statement of acquisition of beneficial ownership by individuals | NASDAQ:AWH | Aspira Womans Health Inc |
| 12/19/2023 | 8:00AM | GlobeNewswire Inc. | Aspira Women’s Health to Host R&D Day With Updates on the Development of the Company's Ovarian Cancer and Endometriosis Tests on January 4, 2024 | NASDAQ:AWH | Aspira Womans Health Inc |
| 12/14/2023 | 8:00AM | GlobeNewswire Inc. | Aspira Women’s Health to Participate in Corporate Access Events During JP Morgan Healthcare Conference Week 2024 | NASDAQ:AWH | Aspira Womans Health Inc |
| 12/08/2023 | 5:34PM | Edgar (US Regulatory) | Form 3 - Initial statement of beneficial ownership of securities | NASDAQ:AWH | Aspira Womans Health Inc |
| 12/08/2023 | 5:28PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:AWH | Aspira Womans Health Inc |
| 12/08/2023 | 9:46AM | GlobeNewswire Inc. | New to The Street TV Features Five Corporate Guest Interviews, Episode 537 Airs on the FOX Business Network, Monday, December 11, 2023, at 10:30 PM PT | NASDAQ:AWH | Aspira Womans Health Inc |
| 12/07/2023 | 9:20AM | GlobeNewswire Inc. | New to The Street TV Announces Its Episode 536 Lineup, Five Corporate Guest Interviews, Broadcasted as Sponsored Program on Bloomberg TV, Tonight, Thursday, December 7, 2023, at 9:30 PM PT | NASDAQ:AWH | Aspira Womans Health Inc |